clorzoxazon 250 mg
gedeon richter romania sa - romania - chlorzoxazonum - compr. - 250mg - miorelaxante centrale derivati de oxazol, tiazina si triazina
clorzoxazona arena 250 mg
arena group sa - romania - chlorzoxazonum - compr. - 250mg - miorelaxante centrale derivati de oxazol, tiazina si triazina
dysport
ipsen limited - toxina botulinica de tip a - pulb. pt. sol. inj. - 500 ui - miorelaxante periferice alte miorelaxante cu actiune periferica
ditilin-darnita solutie injectabila 20 mg/ml
darnita sap, firma farmaceutica - suxamethonii iodidum - solutie injectabila - 20 mg/ml
esmeron 10 mg/ml soluţie injectabilă
schering-plough central east ag - rocuronii bromidum - soluţie injectabilă - 10 mg/ml
esmeron 10 mg/ml soluţie injectabilă
schering-plough central east ag - rocuronii bromidum - soluţie injectabilă - 10 mg/ml
bridion
merck sharp & dohme b.v. - sugammadex - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. pentru populația pediatrică: sugammadex este recomandat numai pentru reversia de rutină de rocuronium-a indus blocada la copii și adolescenți.
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
sevorane 250 mg
abbvie s.r.l. - italia - sevofluranum - lichid volatil pt. inhalat - 250mg - anestezice generale derivati halogenati ai hidrocarburilor